Biomedical Lab is involved in the European DESIRE Program with an Innovative Parkinson’s Tracking Project

DESIRE is a three-year, €1.5 million project funded by the COSME Single Market Programme.

The DESIRE Eurocluster project was launched on September 1, 2022, and will last for 36 months. It comprises one business support organization and four clusters from Austria, France, Romania, and Poland.

In the context of the DESIRE Open Call 2023-2024, Biomedical Lab s.r.l. has been selected as one of the winners with the project entitled “A new digital tool for the selective tracking of the Parkinsonian motor signs – PD-Watch.”

Biomedical Lab s.r.l. will receive €30,000 in direct funding and services for the development of the above-mentioned project.

For more information about the DESIRE project, please visit:

https://desire-development-of-e-health.b2match.io/

https://desire-development-of-e-health.b2match.io/page-1741